PASO Automated Template Matching for PVC Ablation
NCT04778696 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144
Last updated 2021-03-03
Summary
Pacemapping is an essential tool during ablation of idiopathic PVC and VT. Automated template matching has been shown to have a significant influence on PVC ablation procedures, but the PASO module of CARTO3 has not been studied in a randomized trial. The Aim of this study is to evaluate the additional benefit of PASO template matching on PVC ablation procedure with regard to procedural parameters and outcome when compared with conventional pace mapping. A total of 144 pts will be randomised in a 1:1 fashion to PVC ablation guided by conventional pacemapping vs PVC ablation guided by PASO pacemapping. Patients will be follow up with Holter-ECG and TTE after 3 and 12 months.
Conditions
- PVC - Premature Ventricular Complex
- Cardiomyopathies
- Heart Failure
- Ventricular Tachycardia
Interventions
- PROCEDURE
-
PASO Pacemapping
Using the PASO pacemapping visualisation module of CARTO3
- PROCEDURE
-
Conventional Pacemapping
without visualisation in 3D mapping
Sponsors & Collaborators
-
Biosense Webster, Inc.
collaborator INDUSTRY -
Universitätsklinikum Köln
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-05
- Primary Completion
- 2022-07-01
- Completion
- 2022-10-01
Countries
- Germany
Study Locations
More Related Trials
-
Ventricular Arrhythmia Ablation With the Use of Non-Invasive ECG Imaging Technology
NCT04219501 ·Status: WITHDRAWN ·Phase: NA
-
Cardiac ResynchrOniSation Via Stimulation of the LEFT Bundle in AF Patients.
NCT05162716 ·Status: UNKNOWN
-
Abbott Ventricular Tachycardia PAS
NCT05839873 ·Status: ACTIVE_NOT_RECRUITING
-
Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization
NCT00187278 ·Status: COMPLETED ·Phase: NA
-
Reduction of Fluoroscopy Exposure During Atrial Fibrillation Ablation
NCT02137798 ·Status: COMPLETED ·Phase: NA
-
Personalized Atrial Fibrillation Ablation With QDOT
NCT04298177 ·Status: UNKNOWN ·Phase: PHASE4
-
Guided Radiofrequency Ablation Using the CARTO® 3 and NavX™ Systems for the Treatment of Paroxysmal Atrial Fibrillation
NCT01036724 ·Status: TERMINATED
-
An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac Arrhythmias
NCT04750798 ·Status: RECRUITING
-
The Added Value of Three-dimensional Electroanatomic Mapping For Accurate Delivery Of Pulsed Field Ablation In The Pulmonary Veins Compared To Pulsed Field Ablation With Fluoroscopy And/Or Intracardiac Echocardiography Alone In The Treatment Of Atrial Fibrillation: MAP-PFA Study
NCT07014423 ·Status: COMPLETED ·Phase: NA
-
A Study Assessing Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter
NCT05373862 ·Status: COMPLETED ·Phase: NA
-
Clinical Impact of Autonomic Modulation After Pulmonary Vein Isolation
NCT02733913 ·Status: COMPLETED
-
Rate RESPONSIVe Pacing in Patients With Permanent AF Underwent AV Node ABLation and bivEntricular Pacing (RESPONSIBLE)
NCT02354989 ·Status: COMPLETED ·Phase: NA
-
The Low Voltage Guided Ablation Trial of Persistent Atrial Fibrillation
NCT02732626 ·Status: COMPLETED ·Phase: NA
-
Comparison of Pulmonary Vein Isolation Versus AV Nodal Ablation With Biventricular Pacing for Patients With Atrial Fibrillation With Congestive Heart Failure (PABA CHF)
NCT00599976 ·Status: COMPLETED ·Phase: NA
-
The Effect of Pulse Field Ablation on Atrial Mechanics in Catheter Ablation of Paroxysmal Atrial Fibrillation
NCT06557876 ·Status: RECRUITING ·Phase: NA
-
Clinical Investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation
NCT03513029 ·Status: UNKNOWN ·Phase: NA
-
Left Atrial Arrhythmia Substrate Identification After Confirmed durABLE Pulmonary Vein Isolation
NCT04111731 ·Status: COMPLETED ·Phase: NA
-
Pulsed-field Ablation in Patients With Persistent Atrial Fibrillation
NCT05922917 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
QDOT Based PVI for Atrial Fibrillation Treatment - The peQasus Study
NCT05710822 ·Status: UNKNOWN
-
Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia
NCT02130765 ·Status: TERMINATED ·Phase: NA
-
Atrial Fibrillation Progression Trial
NCT01570361 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of the Impact of Pulsed Field Ablation on Autonomic Nervous System Modulation in Paroxysmal Atrial Fibrillation
NCT06647485 ·Status: RECRUITING ·Phase: NA
-
Ablation of the Pulmonary Veins for Paroxysmal Afib
NCT00744874 ·Status: COMPLETED ·Phase: PHASE4
-
The TRAMPOLINE VT Study
NCT05152784 ·Status: COMPLETED ·Phase: NA
-
Isolation of Pulmonary Veins With PVAC GOLD in Elderly Patients
NCT04023461 ·Status: COMPLETED ·Phase: PHASE4